Fuji Pharma

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Fuji Pharma has already paid €0.12 in dividends. The last payout was in June.

Financials

In the last quarter, Fuji Pharma had revenue of €84.4m and net profit of €5.96m

(EUR)	June 2026	YoY
Revenue	84.4m	11.25%
Gross profit	28.73m	0.16%
Net profit	5.96m	86.16%
EBITDA	11.06m	7.51%

Fundamentals

Metric	Value
Market capitalization	€273.78m
Number of shares	26.12m
52-week high/low	€14.54 - €8.81
Dividend yield	2.52%
Dividends TTM	€0.26
Beta	0.33
P/E ratio	15.51
PEG ratio	-2.81
P/B ratio	0.93
P/S ratio	0.80

Company profile

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.